TickerFacts.

Compare

Angiodynamics Inc vs Tactile Systems Technology Inc vs PROCEPT BioRobotics Corp vs SkinHealth Systems Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAngiodynamics Inc
ANGO		Tactile Systems Technology Inc
TCMD		PROCEPT BioRobotics Corp
PRCT		SkinHealth Systems Inc.
SKIN
Year ended2026-05-312025-12-312025-12-312025-12-31
Revenue$320.17M$329.52M$308.05M$300.79M
Revenue growth (YoY)+9.5%+12.5%+37.2%-10.0%
Gross margin54.6%75.9%63.7%65.3%
Operating margin-12.5%8.9%-33.7%-6.9%
Net margin-11.5%5.8%-31.0%-3.2%
Net income-$36.74M$19.09M-$95.57M-$9.52M
EPS (Diluted)-$0.88$0.82-$1.72-$0.16
Operating cash flow$3.09M$42.81M-$48.98M$37.48M
Free cash flow$508.0K$40.43M-$58.34M$37.18M
Cash & equivalents$53.86M$83.45M$286.50Mn/a
Total assets$267.16M$273.94M$508.08M$499.80M
Total liabilities$96.34M$55.04M$142.21M$438.75M
Shareholders' equity$170.82M$218.90M$365.87M$61.06M
Return on year-end equity-21.5%8.7%-26.1%-15.6%
Shares outstanding41.70M22.44M56.32M127.52M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAngiodynamics IncTactile Systems Technology IncPROCEPT BioRobotics CorpSkinHealth Systems Inc.
Latest$320.17M
Ended 2026-05-31		$329.52M
Ended 2025-12-31		$308.05M
Ended 2025-12-31		$300.79M
Ended 2025-12-31
1 year earlier$292.50M
Ended 2025-05-31		$292.98M
Ended 2024-12-31		$224.50M
Ended 2024-12-31		$334.29M
Ended 2024-12-31
2 years earlier$303.91M
Ended 2024-05-31		$274.42M
Ended 2023-12-31		$136.19M
Ended 2023-12-31		$397.99M
Ended 2023-12-31
3 years earlier$338.75M
Ended 2023-05-31		$246.78M
Ended 2022-12-31		$75.01M
Ended 2022-12-31		$365.88M
Ended 2022-12-31
4 years earlier$316.22M
Ended 2022-05-31		$208.06M
Ended 2021-12-31		$34.47M
Ended 2021-12-31		$260.09M
Ended 2021-12-31